Sunday, September 22, 2019 4:40:49 PM
Are all OTC Reverse Mergers scams? NO! Proof:
Here are the top 10 US cannabis companies. Notice how they took their company public (RM=Reverse Merger). Notice what exchange they list on. And notice what type of company they merged with (mostly mineral/mining sector). GRN is doing what the top companies in the sector have successfully done. GRN is following the cannabis model, no question.
1. Trulieve Cannabis Inc > Schyan Exploration Inc RM 9/2018 on OTC
2. Curaleaf Holdings Corp > Lead Ventures Inc RM 10/2018 on OTC
3. Green Thumb Industries > Bayswater Uranium Corp RM 6/2018 on OTC
4. Tilt Holdings > Santé Veritas Holdings Inc (+ 3 others) RM 12/2018 on OTC
5. MedMen Enterprises > OutdoorPartner Media Corp RM 4/2018 on OTC
6. Cresco Labs > Randsburg International Gold Corp (empty shell) RM 10/2018 on OTC
7. Harvest Health & Recreation > RockBridge Resources Inc RM 11/2018 on OTC
8. Tilray > IPO on NASDAQ 7/2018 (Don't sell MJ in the USA)
9. Marimed Inc. > IPO on OTC 5/2012
10. Charlotte's Web Holdings > IPO on CSE 8/2012
? GRN Holding Corp > Discovery Gold Corp RM on 7/2019 on OTC
Here are the top 10 US cannabis companies. Notice how they took their company public (RM=Reverse Merger). Notice what exchange they list on. And notice what type of company they merged with (mostly mineral/mining sector). GRN is doing what the top companies in the sector have successfully done. GRN is following the cannabis model, no question.
1. Trulieve Cannabis Inc > Schyan Exploration Inc RM 9/2018 on OTC
2. Curaleaf Holdings Corp > Lead Ventures Inc RM 10/2018 on OTC
3. Green Thumb Industries > Bayswater Uranium Corp RM 6/2018 on OTC
4. Tilt Holdings > Santé Veritas Holdings Inc (+ 3 others) RM 12/2018 on OTC
5. MedMen Enterprises > OutdoorPartner Media Corp RM 4/2018 on OTC
6. Cresco Labs > Randsburg International Gold Corp (empty shell) RM 10/2018 on OTC
7. Harvest Health & Recreation > RockBridge Resources Inc RM 11/2018 on OTC
8. Tilray > IPO on NASDAQ 7/2018 (Don't sell MJ in the USA)
9. Marimed Inc. > IPO on OTC 5/2012
10. Charlotte's Web Holdings > IPO on CSE 8/2012
? GRN Holding Corp > Discovery Gold Corp RM on 7/2019 on OTC
Recent MAJI News
- NexTel Medical Corp Announces Pivotal Milestone in Commercial Launch of Patent-Protected NANOG DNA Cancer Screening Test • GlobeNewswire Inc. • 04/07/2026 02:30:00 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 03/30/2026 04:15:02 AM
- Form 253G1 - • Edgar (US Regulatory) • 03/27/2026 07:12:08 PM
- Form 1-A POS - • Edgar (US Regulatory) • 03/26/2026 08:25:15 PM
- Form 1-A POS - • Edgar (US Regulatory) • 03/20/2026 08:23:33 PM
- Exousia Pro, Inc. Announces Favorable Litigation Settlement, Highlighting Significant Debt Elimination and Share Cancellation to Enhance Shareholder Value • GlobeNewswire Inc. • 03/16/2026 02:15:00 PM
- Form 1-A POS - • Edgar (US Regulatory) • 03/11/2026 07:11:39 PM
- Exousia Pro, Inc. Announces Strategic Elimination of Future Dilutive Issuance of 47 Million Shares, Progresses Toward Definitive Agreements for Telehealth Acquisitions • GlobeNewswire Inc. • 03/05/2026 06:00:20 PM
- Form 1-A POS - • Edgar (US Regulatory) • 02/19/2026 09:39:04 PM
- Form 253G2 - • Edgar (US Regulatory) • 02/11/2026 08:06:08 PM
- Exousia Pro, Inc. Accelerates Strategic Expansion with Third Telehealth Acquisition; Strengthens Pathway to Low-Cost Customer Acquisition • GlobeNewswire Inc. • 02/10/2026 03:30:00 PM
- Form 253G2 - • Edgar (US Regulatory) • 01/15/2026 06:47:01 PM
- Form 253G1 - • Edgar (US Regulatory) • 01/14/2026 09:54:45 PM
- Form 1-A POS - • Edgar (US Regulatory) • 12/31/2025 12:32:47 PM
- Form 253G2 - • Edgar (US Regulatory) • 12/29/2025 08:29:49 PM
- Exousia Pro, Inc. Announces Executed LOI for Strategic Acquisition of High-Revenue Telehealth Platform to Accelerate Nutraceutical Commercialization • ACCESS Newswire • 12/11/2025 05:15:00 PM
- Exousia Pro, Inc. Revolutionizes Nutraceuticals With Launch Of Maxasome(TM): The First All-Natural, Biologically Active Exosomal Supplement • ACCESS Newswire • 12/05/2025 04:00:00 PM
- Form 253G2 - • Edgar (US Regulatory) • 12/04/2025 09:35:28 PM
- Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms • ACCESS Newswire • 12/02/2025 06:45:00 PM
- Exousia Pro Initiates Strategic Realignment, Acquires Controlling Stake in SEC-Reporter Lamy (LMMY) in All-stock Exchange Transaction for Exousia AI, to Advance Growth and Enhance Shareholder Value • ACCESS Newswire • 11/17/2025 08:40:00 PM
- Exousia Pro Announces Breakthrough In Exosome-Based Delivery • ACCESS Newswire • 11/04/2025 03:40:00 PM
- Exousia Pro is Excited to Announce that it has Received Orphan Drug Designation from the FDA • ACCESS Newswire • 10/28/2025 02:20:00 PM
- Exousia Pro Announces Groundbreaking Study to Revolutionize the Global Edibles Market with CBD-Loaded Exosomes • ACCESS Newswire • 09/29/2025 04:35:00 PM
- Exousia Pro Reports Positive Outcome in Legal Proceeding • ACCESS Newswire • 09/26/2025 02:30:00 PM
